Aspira Women's Health
OTC: AWHLAustin, US · Delaware corporation
BiotechHealthtech
Founders & leadership
SM
Sandra MilliganPresident
NS
Nicole SandfordChief Executive Officer and Interim Chief Financial Officer
RB
Robert BeecheyExecutive
VB
Valerie B. PalmieriExecutive
Board
WP
Winfred ParnellBoard director
SC
Stefanie CavanaughBoard director
CF
Celeste FralickBoard director
EO
Ellen O'Connor VosBoard director
JH
Jannie HerchukBoard director
VG
Veronica G. H. JordanBoard director
JT
James T. LaFranceBoard director
JS
James S. BurnsBoard director
Reported raises · per SEC filings
Form D private placements$25.2M disclosed across 6 rounds · 2020–2026
▶$1.5MraisedJun 2026 · 19 investors · BiotechnologyRule 506(b)
▶$1.5MraisedJun 2026 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- WINFRED PARNELLDirector
- JEFFREY COHENDirector
- ELLEN BEAUSANGDirector
- CYNTHIA HUNDORFEANDirector
- JOHN STRAHLEYExecutive Officer
- JOHN FRASERExecutive Officer, Director
- Jane PINE WOODDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedSep 2025 · 19 investors · BiotechnologyRule 506(b)
▶$3MraisedSep 2025 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ELLEN BEAUSANGDirector
- MICHAEL BUHLEExecutive Officer
- Jane PINE WOODDirector
- JACK FRASERDirector
- BRIAN HUNGERFORDExecutive Officer
- CYNTHIA HUNDORFEANDirector
- JEFFREY COHENDirector
- WINFRED PARNELLDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.4MraisedMar 2025 · 27 investors · BiotechnologyRule 506(b)
▶$1.4MraisedMar 2025 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ELLEN BEAUSANGDirector
- WINFRED PARNELLDirector
- MICHAEL BUHLEExecutive Officer
- JOHN RAGARDDirector
- JANNIE HERCHUKDirector
- CELESTE FRALICKDirector
- JAMES CRAWFORDExecutive Officer
- ELLEN O'CONNOR-VOSDirector
- STEFANIE CAVANAUGHDirector
- Offering amount
- $1.4M
- Amount sold
- $1.4M
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.9MraisedJul 2024 · 21 investors · BiotechnologyRule 506(b)
▶$1.9MraisedJul 2024 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Winfred ParnellDirector
- Stefanie CavanaughDirector
- Celeste FralickDirector
- Sandra MilliganExecutive Officer
- Ellen O'Connor VosDirector
- Nicole SandfordExecutive Officer, Director
- Jannie HerchukDirector
- Offering amount
- $1.9M
- Amount sold
- $1.9M
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.5MraisedFeb 2024 · 7 investors · BiotechnologyRule 506(b)
▶$6.5MraisedFeb 2024 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Minh MerchantExecutive Officer
- Lynn O'Connor VosDirector
- Nicole SandfordExecutive Officer, Director
- Stefanie CavanaughDirector
- Winfred ParnellDirector
- Jannie HerchukDirector
- Celeste FralickDirector
- Torsten HombeckExecutive Officer
- Jody BerryExecutive Officer
- Offering amount
- $6.5M
- Amount sold
- $6.5M
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11MraisedJul 2020 · 8 investors · Other Health CareRule 506(b)
▶$11MraisedJul 2020 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Veronica G. H. JordanDirector
- James T. LaFranceDirector
- James S. BurnsDirector
- Robert BeecheyExecutive Officer
- David R. SchreiberDirector
- Nancy G. CocozzaDirector
- Valerie B. PalmieriExecutive Officer, Director
- Offering amount
- $11M
- Amount sold
- $11M
- Minimum investment
- $150K
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlapLabcorp24 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
Quest Diagnostics20 shared keywordsQuest Diagnostics is the world's leading provider of diagnostic information services, serving one in three adult Americans and half of US physicians and hospitals. The company offers diagnostic insights and testing services to consumers and healthcare providers to support health decision-making.
Cancerresearchuk17 shared keywordsCancer Research UK funds research across discovery, detection, prevention and treatment of cancer to improve patient outcomes and extend survival. It operates as a research funder and scientific organization serving academic and clinical researchers.
American Cancer Society (ACS)16 shared keywordsThe American Cancer Society is a nonprofit cancer-fighting organization that combats cancer through advocacy, research, and patient support. It provides information, guidance, caregiver resources, screening guidance, and clinical trial navigation for cancer patients, families, and caregivers, and funds cancer research.
MD Anderson Cancer Center14 shared keywordsUT MD Anderson is a cancer hospital providing cancer treatment, prevention, clinical care, and research, including new therapies and clinical trials for cancer patients. It is ranked among the top hospitals in the U.S. for cancer care.
Companies competing with Aspira Women's Health for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- How much funding has Aspira Women's Health raised?
- Aspira Women's Health has disclosed $25.2M raised across 6 rounds.
- Where is Aspira Women's Health headquartered?
- Aspira Women's Health is headquartered in Austin, US.